Abate Kristin sold KPTI
September 3, 2025 · Form 4 insider transaction
Abate Kristin sold 12 shares of Karyopharm Therapeutics Inc. at $6.78 per share, a transaction worth $81.36. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
12
Price
$6.78
Total value
$81.36
InsiderAbate Kristin
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 3, 2025
Filing dateSeptember 4, 2025
Shares owned after9,463
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 27, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.